France: Ethypharm to enter Spanish market with acquisition of Altan Pharma

Ethypharm, a European pharmaceutical company focused on the therapeutic areas of the central nervous system and critical care headquartered in France, is making a move into the Spanish market by entering into a definitive agreement to acquire Altan Pharma, a specialty pharmaceutical company that develops, manufactures and markets injectable medicines for hospital use. With the…

You must be a HMI Subscriber to view this content.

Subscribe Now »